Maravai LifeSciences Inc. (MRVI) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Maravai LifeSciences Inc... (MRVI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.70

0.16 (3.52%)

At close: Jan 15, 2025, 10:31 AM

Maravai LifeSciences Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Biologics Safety Testing Segment Revenue	15.25M	18.16M	15.32M	15.64M	15.65M	17.57M	15.42M	16.38M	17.48M	20.64M	15.93M	16.63M	18.21M	52.95M
Biologics Safety Testing Segment Revenue Growth	-16.02%	+18.57%	-2.05%	-0.07%	-10.95%	+13.95%	-5.85%	-6.30%	-15.30%	+29.55%	-4.16%	-8.69%	-65.61%	n/a
Nucleic Acid Production Segment Revenue	49.95M	46.02M	58.83M	51.23M	53.27M	61.45M	189.29M	174.88M	225.25M	223.65M	212.51M	182.90M	192.52M	372.03M
Nucleic Acid Production Segment Revenue Growth	+8.54%	-21.77%	+14.83%	-3.82%	-13.32%	-67.54%	+8.24%	-22.36%	+0.71%	+5.24%	+16.19%	-5.00%	-48.25%	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Asia Pacific Revenue	97.44M
Asia Pacific Revenue Growth	n/a
Emea Revenue	49.92M
Emea Revenue Growth	n/a
Latin And Central America Revenue	527.00K
Latin And Central America Revenue Growth	n/a
North America Revenue	141.06M
North America Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Selling, General, and Administrative Revenue	39.09M	40.56M	31.20M	33.63M	38.86M	35.38M	38.67M	37.20M	30.80M	28.06M	33.20M	25.58M	25.19M	24.09M	23.24M	41.62M	20.51M	15.99M	16.13M	15.78M
Selling, General, and Administrative Revenue Growth	-3.62%	+30.00%	-7.22%	-13.48%	+9.86%	-8.52%	+3.95%	+20.81%	+9.74%	-15.48%	+29.78%	+1.56%	+4.58%	+3.65%	-44.17%	+102.93%	+28.28%	-0.86%	+2.17%	n/a
Research and Development Revenue	4.34M	5.28M	5.03M	4.59M	4.35M	4.19M	4.14M	5.01M	5.39M	4.27M	3.69M	9.18M	1.95M	1.93M	2.16M	2.09M	1.87M	1.60M	3.74M	979.00K
Research and Development Revenue Growth	-17.79%	+5.01%	+9.53%	+5.68%	+3.65%	+1.18%	-17.28%	-7.01%	+26.09%	+15.67%	-59.77%	+370.97%	+0.93%	-10.72%	+3.44%	+11.99%	+16.75%	-57.26%	+282.43%	n/a